
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is a leading provider in the long-term care pharmacy industry, with a strong focus on technology-enabled services that improve clinical outcomes and reduce costs for residents of assisted living facilities and other long-term care facilities. The company's strong financial flexibility, ongoing growth through M&A and greenfield expansions, and a robust suite of technology assets differentiate it in the fragmented market. Despite potential risks such as regulatory changes and supply chain disruption, we believe Guardian Pharmacy Service's strong positioning and growth opportunities make it a sound investment.
Bears say
Guardian Pharmacy Service is facing strong competition in its market and has been relying on non-sustainable drivers, such as favorable payor settlements and M&A integration, for its recent earnings beat. The company also faces potential revenue impact due to the IRA, and its market share is only at 13%. Additionally, the company's reliance on pharmaceutical and medical product sales may be a risk in the long-term.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares